R&D | November 25, 2025
Alzheimer’s testing goes painless, homebound with Neurogen-Tasso partnership
The collaboration aims to make Alzheimer’s biomarker testing more accessible and less intimidating
The collaboration aims to make Alzheimer’s biomarker testing more accessible and less intimidating
The proposed transaction will be effected as a share swap
These certifications reflect the company's continuous commitment to maintaining international standards of environmental sustainability as well as occupational health and safety
Millions of stroke survivors across the world may soon have a new defense
The therapy -- Ryoncil (remestemcel-L-rknd) -- will be tested in adults with severe steroid-refractory acute graft-versus-host disease
The Eurasian Patent Organization (EAPO) has granted Patent, protecting the company’s sublingual delivery technology for anticancer drugs used to treat autoimmune and neurodegenerative diseases
The partnership combines Croda’s deep expertise in smart science and global market reach with Amino’s advanced capabilities in precision manufacturing of amino acids
Innovent plans to soon submit a new drug application (NDA) to China’s National Medical Products Administration
HER2-mutant NSCLC typically has a poor prognosis and limited treatment options
The full approval is based on the results from the pivotal Phase 3 EPCORE FL-1 study
Subscribe To Our Newsletter & Stay Updated
